Insider trades

Sujata Tyagi Dayal, Director of Emergent BioSolutions EBS, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $201.1K. The latest trade was on 05/01.

Sujata Tyagi Dayal

Director
First filing
23/05/30
Trades
10 trades
Buys / sales
0 / 3
12-month net buying
−$201.1K
Last trade
05/01

Trading activity

Transactions

Trade type
EBS
Open-market sale10b5-1 plan05/0105/0413,761 sh2 trades$8.40avg.$115,610.36−12.0%
Open-market sale25/11/0725/11/108,552 sh$10.00$85,520−8.8%